Yohei Doi

Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study

Yiyun Liu, Yang Wang, Timothy R. Walsh et al. · The Lancet Infectious Diseases · 2015 · 5.4K citations

Life Sciences, Microbiology, Molecular Biology +16

Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial

Matteo Bassetti, Roger Echols, Yuko Matsunaga et al. · The Lancet Infectious Diseases · 2020 · 792 citations

Life Sciences, Infectious Diseases, Microbiology +14

Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae

David van Duin, Judith J. Lok, Michelle Earley et al. · Clinical Infectious Diseases · 2017 · 652 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens

Zubair Qureshi, David L. Paterson, Brian A. Potoski et al. · Antimicrobial Agents and Chemotherapy · 2012 · 563 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

16S Ribosomal RNA Methylation: Emerging Resistance Mechanism against Aminoglycosides

Yohei Doi, Y. Arakawa · Clinical Infectious Diseases · 2007 · 558 citations

Life Sciences, Microbiology, Molecular Biology +17